CALM1

Calmodulin-1 · P0DP23 · CALM1 on Sugi Atlas →

25,893 patent compounds predicted against CALM1, 18,190 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL224550 SCHEMBL224550 0.47 6/20
SCHEMBL65276 SCHEMBL65276 0.46 4/20
SCHEMBL43447 SCHEMBL43447 0.44 4/20
SCHEMBL108087 SCHEMBL108087 0.70 3/20
SCHEMBL58054 SCHEMBL58054 0.58 3/20
SCHEMBL58055 SCHEMBL58055 0.58 3/20
SCHEMBL427550 SCHEMBL427550 0.52 3/20
SCHEMBL356412 SCHEMBL356412 0.51 3/20
Ammonia Solution, Strong Ammonia Solution, Strong (SCHEMBL303558) 0.51 3/20
SCHEMBL175622 SCHEMBL175622 0.49 3/20
SCHEMBL436880 SCHEMBL436880 0.49 3/20
SCHEMBL64288 SCHEMBL64288 0.48 3/20
SCHEMBL88823 SCHEMBL88823 0.45 3/20
SCHEMBL402666 SCHEMBL402666 0.44 3/20
SCHEMBL410079 SCHEMBL410079 0.42 3/20
SCHEMBL63547 SCHEMBL63547 0.41 3/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL444357) 0.41 3/20
7-Hydroxyflavone 7-Hydroxyflavone (SCHEMBL312148) 1.00 2/20
SCHEMBL311405 SCHEMBL311405 0.82 2/20
SCHEMBL108050 SCHEMBL108050 0.72 2/20

Clinical trials — most relevant to CALM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COMS for Chronic Ulcers Treatment PHASE4RECRUITING
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease PHASE2COMPLETED
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
The Response To Ajmaline Provocation in Healthy Subjects PHASE2UNKNOWN
S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM) PHASE1COMPLETED
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations EARLY_PHASE1COMPLETED
Glutamine Supplementation in People With Immune Dysregulation EARLY_PHASE1WITHDRAWN
Prevalence of Constitutional Mismatch-repair Deficiency Among Suspected Neurofibromatosis Type 1/Legius Syndrome Children Without a Malignancy and Without a NF1 or SPRED1 Mutation nanUNKNOWN
The Prevalence of RYR1-related Disease nanNOT_YET_RECRUITING
A Natural History Study of RYR1-Related Disorders nanRECRUITING
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life nanCOMPLETED
Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study nanWITHDRAWN
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia nanRECRUITING
ADH1 and ADH2 Disease Monitoring Study (DMS) nanACTIVE_NOT_RECRUITING
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy nanRECRUITING
Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) in Ischaemic, Inflammatory and Takotsubo Cardiomyopathy (MEMORY) nanCOMPLETED
Radicle Calm RDH: A Study Assessing the Impact of Health and Wellness Products on Feelings of Anxiety and Related Health Outcomes nanCOMPLETED
Comparison of Two Methods to Diagnose Coronary Artery Disease nanCOMPLETED
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster. nanRECRUITING
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation nanRECRUITING
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders nanUNKNOWN
Transcranial Magnetic Stimulation (TMS) Studies of Dystonia nanCOMPLETED
Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors nanUNKNOWN
Pediatric Cardiomyopathy Mutation Analysis nanRECRUITING
Joint Determinants of Bone Density and CVD Calcification nanCOMPLETED
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) nanNOT_YET_RECRUITING
Evaluation of A Clinical Diagnostic Test for CRDS nanRECRUITING
Clinical and Genetic Study of Autism Spectrum Disorder nanCOMPLETED
Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CALM1 binder may also engage these)

ProteinNameSimilarity
P0DP33 1.000 P0DP33 →
Q6YNX6 1.000 Q6YNX6 →
P0DP28 1.000 P0DP28 →
P0DP25 1.000 P0DP25 →
P0DP26 1.000 P0DP26 →
P0DP24 1.000 P0DP24 →
P0DP29 1.000 P0DP29 →
P0DP27 1.000 P0DP27 →
P62144 1.000 P62144 →
P62156 1.000 P62156 →
Q7T3T2 1.000 Q7T3T2 →
P02594 1.000 P02594 →
Q9U6D3 1.000 Q9U6D3 →
P62151 1.000 P62151 →
Q5RAD2 1.000 Q5RAD2 →
Q6R520 1.000 Q6R520 →
P0DP34 1.000 P0DP34 →
P62157 1.000 P62157 →
Q71UH6 1.000 Q71UH6 →
P0DP30 1.000 P0DP30 →
P0DP31 1.000 P0DP31 →
Q6IT78 1.000 Q6IT78 →
P0DP35 1.000 P0DP35 →
Q9UB37 1.000 Q9UB37 →
P21251 1.000 P21251 →
P07463 1.000 P07463 →
P62149 1.000 P62149 →
Q6PI52 1.000 Q6PI52 →
Q95NR9 1.000 Q95NR9 →
P62160 1.000 P62160 →